Price A R
Division of Research Investigations, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD 20852, USA.
Acad Med. 1998 May;73(5):467-72. doi: 10.1097/00001888-199805000-00009.
Given the concerns expressed by members of the academic and legal community about whether (and how) to handle anonymous and pseudonymous allegations of scientific misconduct, this paper summaries the experiences of the Office of Research Integrity and its predecessor from 1989 through 1997. Although the record shows that research institutions and the ORI have treated such allegations seriously, the fraction of complainants to the ORI who remain anonymous is small (8% of 986 allegations); few anonymous complaints are sufficiently substantive to be pursued (4% of the 357 formal cases opened in the ORI); and only 1 of these 13 cases resulted in an ORI finding of scientific misconduct.
鉴于学术界和法律界成员对如何处理有关科学不端行为的匿名和假名指控（以及是否应处理）所表达的担忧，本文总结了研究诚信办公室及其前身在1989年至1997年期间的经验。尽管记录显示研究机构和研究诚信办公室认真对待了此类指控，但向研究诚信办公室投诉且仍保持匿名的投诉人比例很小（986项指控中的8%）；很少有匿名投诉内容充分到值得追查（在研究诚信办公室开启的357起正式案件中占4%）；而在这13起案件中，只有1起导致研究诚信办公室认定存在科学不端行为。
